KLA’s 6.9% jump: growth supports a measured buy

I view the +6.89% move to $163.53 as a sharp rebound, not a reason to chase aggressively; it does not change my view. The business data support the optimism: Q3 revenue rose 28.9% year over year, net income rose 38.1%, and free cash flow reached $1,336M, up 25.4%. Consensus projects EPS growth of 57.6% in FY 2027 and 23.1% in FY 2028, bringing forward P/Es to 28.4x and 23.0x, respectively, versus 41.0x trailing. That growth makes valuation more defensible, while the 21.9% three-month decline and 45.8% gap below the 52-week high put yesterday’s surge in context. With 34.5% median-target upside, I’ll buy modestly rather than infer a catalyst or treat one session as proof of a trend reversal.